Daniel A. Gaudet
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 241 publications
New and Emerging Therapeutic Targets for ApoB-Containing Particles Lowering.
Journal: Circulation research
Published: June 04, 2026
In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia.
Journal: The New England journal of medicine
Published: May 26, 2026
Efficacy and safety of olezarsen in patients with vs without baseline fibrate use.
Journal: Journal of clinical lipidology
Published: May 13, 2026
Longer-Term Efficacy and Safety of Zodasiran in Patients with Mixed Hyperlipidaemia.
Journal: European journal of preventive cardiology
Published: May 11, 2026
ApoC-III inhibition: from regulatory approval to equitable implementation.
Journal: Nature reviews. Cardiology
Published: March 25, 2026
Kynurenine and Related Metabolites in St. John's Wort (Hypericum perforatum).
Journal: Planta medica
Published: March 20, 2026
Homozygous familial hypercholesterolemia (HoFH) in Canada.
Journal: Atherosclerosis
Published: March 20, 2026
Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.
Journal: Atherosclerosis
Published: March 18, 2026
Treatment of severe hypertriglyceridemia: a new era dawns.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 24, 2026
Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR Trials.
Journal: American journal of preventive cardiology
Published: February 16, 2026
AminoacidDB: a liquid chromatography-tandem mass spectrometry-based toolkit for the untargeted analysis of non-protein amino acids.
Journal: The Analyst
Published: January 16, 2026
Last Updated: 09/26/2026